Key references: Management of women with pre-existing diabetes during pregnancy

  • Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care 2019;42(8):1593-603. https://www.ncbi.nlm.nih.gov/pubmed/31177185
  • American Diabetes Association. 13. Management of diabetes in pregnancy: Standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S137-S43. https://www.ncbi.nlm.nih.gov/pubmed/29222384
  • Department of Health. Clinical practice guidelines. Pregnancy care. Canberra: Australian Government Department of Health; 2018. http://www.health.gov.au/internet/main/publishing.nsf/Content/pregnancycareguidelines
  • Diabetes Canada Clinical Practice Guidelines Expert Committee, Feig DS, Berger H, Donovan L, Godbout A, Kader T, et al. Diabetes and pregnancy. Can J Diabetes 2018;42 Suppl 1:S255-S82. https://www.ncbi.nlm.nih.gov/pubmed/29650105
  • Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 2017;390(10110):2347-59. https://www.ncbi.nlm.nih.gov/pubmed/28923465
  • Forster DA, Moorhead AM, Jacobs SE, Davis PG, Walker SP, McEgan KM, et al. Advising women with diabetes in pregnancy to express breastmilk in late pregnancy (Diabetes and Antenatal Milk Expressing [DAME]): a multicentre, unblinded, randomised controlled trial. Lancet 2017;389(10085):2204-13. https://www.ncbi.nlm.nih.gov/pubmed/28589894
  • Institute of Medicine (US). Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press; 2009. https://www.ncbi.nlm.nih.gov/pubmed/20669500
  • Lowe SA, Bowyer L, Beech A, Robinson H, Armstrong G, Marnoch C, et al. Guideline for the management of nausea and vomiting in pregnancy and hyperemesis gravidarum. Sydney: Society of Obstetric Medicine of Australia and New Zealand; 2019. https://www.somanz.org/approval-of-written-guidelines-by-somanz/
  • McElduff A, Cheung NW, McIntyre HD, Lagstrom JA, Oats JJ, Ross GP, et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005;183(7):373-7. https://www.ncbi.nlm.nih.gov/pubmed/16201957
  • McElduff A, Moses RG. Insulin therapy in pregnancy. Endocrinol Metab Clin North Am 2012;41(1):161-73. https://www.ncbi.nlm.nih.gov/pubmed/22575412
  • Murphy HR, Howgate C, O’Keefe J, Myers J, Morgan M, Coleman MA, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol 2021;9(3):153-64. https://www.ncbi.nlm.nih.gov/pubmed/33516295
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Management of obesity in pregnancy. Melbourne: RANZCOG; 2017. https://www.ranzcog.edu.au/college-statements-guidelines.html
  • Rudland VL, Price SAL, Hughes R, Barrett HL, Lagstrom J, Porter C, et al. ADIPS 2020 guideline for pre-existing diabetes and pregnancy. Aust N Z J Obstet Gynaecol 2020;60(6):E18-E52. https://www.ncbi.nlm.nih.gov/pubmed/33200400
  • Scott EM, Bilous RW, Kautzky-Willer A. Accuracy, user acceptability, and safety evaluation for the freestyle libre flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther 2018;20(3):180-8. https://www.ncbi.nlm.nih.gov/pubmed/29470094